Colossal Biosciences Raises $200M for De-extinction

Biohackers Connect

Hacking the Human System

Cyril

·2 years ago

shared a link post in group #Biohackers Connect

Colossal Biosciences, the startup working to bring back the woolly mammoth, dodo, and Tasmanian tiger, has raised $200M at a $10.2B valuation—more than six times its value just two years ago.

Gene editing could one day cure hereditary diseases like sickle cell and cystic fibrosis, and eventually eradicate them from the human gene pool.

https://www.bloomberg.com..

 #Science is awesome 🧬🦾🚀🤯

Woolly Mammoth, Dodo Get Another Shot as Startup Raises $200 Million

www.bloomberg.com

Woolly Mammoth, Dodo Get Another Shot as Startup Raises $200 Million

Colossal Biosciences, now valued at $10.2 billion, aims to produce a mammoth by 2028.

Todd Smith
Anthropic said that Claude helped discover a previously unknown molecular system that the company said could represent a new gene editing tool akin to CRISPR, which has transformed the creation of new gene therapies. #Leverage Your Biology In a post on X, Anthropic CEO Dario Amodei cautioned that the “precise function, biotechnological utility (if any), or level of significance” of Claude’s discovery isn’t yet clear. But he heralded it as a promising sign of possible future medical breakthroughs by #Artificial Intelligence . “It’s easy to dismiss this as a one-off or curiosity, but we’ve repeatedly seen a pattern where AI performance in new intellectual domains goes from weak to superhuman in a matter of a few years,” he wrote. The discovery was the first notable achievement of a new biotech research group that Anthropic formed in the spring. Amodei said that the milestone was the result of a collaboration between Claude and the company’s life sciences team, who suggested a broad area of research for the AI. Claude then scoured medical literature and genome data and proposed experiments for the Anthropic scientists to carry out to verify the AI’s findings. #Science is awesome 🧬🦾🚀🤯 #Biohackers Connect anthropic.com/news/claude..
www.anthropic.com
Claude discovers a novel enzyme system
In early results from our new life sciences research lab, Claude agents found an enzyme system whose function is still unknown.

Nate
Colossal launched GenoMorph, an #Artificial Intelligence platform that can help identify genetic patterns in extinct species with limited available genomes, such as the dodo. Investor Peter Diamandis also started NeoGenesis Capital, a fund that will back companies built on Colossal’s technology. #Science is awesome 🧬🦾🚀🤯 #Biohackers Connect techcrunch.com/2026/10/14..
techcrunch.com
Colossal Biosciences announces new AI platform to help accelerate de-extinction efforts | TechCrunch
Colossal announced a new AI platform to help accelerate its de-extinction efforts and Peter Diamandis has launched a new fund to back startups who use it.

Embed post to a webpage :

<div data-postid="rogxazp" [...] </div>